Oncology Today with Dr Neil Love

Episode Archive

Episode Archive

32 episodes of Oncology Today with Dr Neil Love since the first episode, which aired on April 9th, 2020.

  • Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition

    September 11th, 2020  |  Season 2020  |  46 mins 35 secs
    bladder cancer, cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a discussion on recent advances in the use of immunotherapy for urothelial bladder cancer with Dr Petros Grivas, moderated by Neil Love, MD.

  • Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition

    September 4th, 2020  |  Season 2020  |  39 mins 39 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice, skin cancer

    For this special edition of Oncology Today, I met with Dr Nikhil Khushalani from Moffitt Cancer Center to discuss recent data and optimal management of cutaneous squamous cell carcinoma.

  • Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition

    August 28th, 2020  |  Season 2020  |  45 mins 25 secs
    cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer.

  • Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard

    August 18th, 2020  |  Season 2020  |  1 hr 26 mins
    cancer, cancer treatment, chemotherapy, dr neil love, follicular lymphoma, immunotherapy, oncology, oncology education, research to practice

    Featuring a roundtable discussion on recent data and optimal management of follicular lymphoma with Drs Carla Casulo and John P Leonard moderated by Neil Love, MD.

  • Oncology Today Special Roundtable: Colorectal Cancer

    August 5th, 2020  |  Season 2020  |  1 hr 30 mins
    cancer, cancer treatment, chemotherapy, colorectal cancer, dr neil love, immunotherapy, oncology, oncology education, research to practice

    Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD.

  • Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson

    August 1st, 2020  |  Season 2020  |  15 mins 34 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.

  • Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer

    June 16th, 2020  |  Season 2020  |  15 mins 13 secs
    cancer, cancer treatment, chemotherapy, dr neil love, oncology, oncology education, pancreatic cancer, research to practice

    Is it worthwhile to treat pancreatic cancer? Dr Michael Pishvaian from Johns Hopkins University discusses the use of the PARP inhibitor olaparib and other new developments in the disease.

  • Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2

    June 5th, 2020  |  Season 2020  |  27 mins 40 secs
    cancer, cancer treatment, chemotherapy, chronic lymphocytic leukemia, cll, covid, covid-19, dr neil love, hematology, oncology, oncology education, research to practice, sars-cov2

    Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2.

  • Oncology Nurse Practitioner Kelly Goodwin Provides a Nurse’s Perspective on Clinical Care for Patients with Lung Cancer at Massachusetts General Hospital During COVID-19

    May 27th, 2020  |  Season 2020  |  16 mins 4 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, nurses, nursing, oncology, oncology education, oncology nurse, research to practice, telemedicine

    Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care.

  • Dr Benjamin Levy on the Management of Lung Cancer in the COVID-19 Era

    May 19th, 2020  |  Season 2020  |  19 mins 32 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.

  • Dr Kathleen Moore Comments on the Management of Ovarian Cancer During the COVID-19 Pandemic

    May 15th, 2020  |  Season 2020  |  14 mins 26 secs
    brca, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, gynecologic cancer, immunotherapy, metastatic, oncology, oncology education, ovarian cancer, parp, research to practice, telemedicine

    Dr Kathleen Moore from the Stephenson Cancer Center and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer.

  • Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic

    May 3rd, 2020  |  Season 2020  |  25 mins 13 secs
    brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine

    Dr Julie Gralow reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19.

  • AACR Virtual Spectacular: Dr Leora Horn Comments on the New COVID-19 Lung Cancer Registry

    April 29th, 2020  |  Season 2020  |  13 mins 20 secs
    cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine

    Dr Leora Horn of Vanderbilt University Medical Center discusses outcomes for patients with lung cancer and COVID-19 as well as the human implications of social distancing.

  • Dr Harold Burstein on Breast Cancer Treatment and COVID-19 at Dana-Farber

    April 24th, 2020  |  Season 2020  |  28 mins 50 secs
    brca, breast cancer, cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, er-positive, her2, her2-positive, immunotherapy, metastatic, oncology, oncology education, parp, research to practice, telemedicine

    Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations.

  • Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle

    April 21st, 2020  |  Season 2020  |  22 mins 4 secs
    dr neil love, research to practice

    Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations.

  • COVID-19 and Prostate Cancer

    April 9th, 2020  |  Season 2020  |  16 mins 16 secs
    dr neil love, research to practice

    COVID-19 and prostate cancer treatment with Drs Neeraj Agarwal, Emmanuel S Antonarakis and A Oliver Sartor.